EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - August 19, 2019 Category: Cancer & Oncology Authors: Aditya Bardia Philippe Aftimos Teeru Bihani Alfred T Anderson-Villaluz JungAh Jung Maureen G Conlan Virginia G Kaklamani Source Type: research